These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21206130)

  • 1. MicroRNA, emerging role as a biomarker of heart failure.
    Kawashima T; Shioi T
    Circ J; 2011; 75(2):268-9. PubMed ID: 21206130
    [No Abstract]   [Full Text] [Related]  

  • 2. Epigenetic Biomarkers and Cardiovascular Disease: Circulating MicroRNAs.
    de Gonzalo-Calvo D; Iglesias-Gutiérrez E; Llorente-Cortés V
    Rev Esp Cardiol (Engl Ed); 2017 Sep; 70(9):763-769. PubMed ID: 28623159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role and significance of microRNA in human cardiovascular disease and forensic science].
    Li LL; Zhao ZQ
    Fa Yi Xue Za Zhi; 2013 Feb; 29(1):39-42. PubMed ID: 23646503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of plasma miRNAs in congestive heart failure.
    Fukushima Y; Nakanishi M; Nonogi H; Goto Y; Iwai N
    Circ J; 2011; 75(2):336-40. PubMed ID: 21157109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MicroRNAs: a role in the development of cardiovascular disease, the possibility for clinical application.].
    Velikiy DA; Gichkun OE; Shevchenko AO
    Klin Lab Diagn; 2018; 63(7):403-409. PubMed ID: 30720954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs as circulating biomarkers for heart failure: questions about MiR-423-5p.
    Kumarswamy R; Anker SD; Thum T
    Circ Res; 2010 May; 106(9):e8; author reply e9. PubMed ID: 20466983
    [No Abstract]   [Full Text] [Related]  

  • 7. Circulating microRNAs in Cardiovascular Diseases.
    Orlicka-Płocka M; Gurda D; Fedoruk-Wyszomirska A; Smolarek I; Wyszko E
    Acta Biochim Pol; 2016; 63(4):725-729. PubMed ID: 27755614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases?
    Fichtlscherer S; Zeiher AM; Dimmeler S
    Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2383-90. PubMed ID: 22011751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs and the heart: small things do matter.
    Papoutsidakis N; Deftereos S; Kaoukis A; Bouras G; Giannopoulos G; Theodorakis A; Angelidis C; Hatzis G; Stefanadis C
    Curr Top Med Chem; 2013; 13(2):216-30. PubMed ID: 23470079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can microRNAs emerge as biomarkers in distinguishing HFpEF versus HFrEF?
    Nair N; Gupta S; Collier IX; Gongora E; Vijayaraghavan K
    Int J Cardiol; 2014 Aug; 175(3):395-9. PubMed ID: 25002320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Density Lipoprotein Function in Cardiovascular Disease and Diabetes Mellitus.
    He Y; Kothari V; Bornfeldt KE
    Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):e10-e16. PubMed ID: 29367232
    [No Abstract]   [Full Text] [Related]  

  • 12. The circulating non-coding RNA landscape for biomarker research: lessons and prospects from cardiovascular diseases.
    E S; Costa MC; Kurc S; Drożdż A; Cortez-Dias N; Enguita FJ
    Acta Pharmacol Sin; 2018 Jul; 39(7):1085-1099. PubMed ID: 29877319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating MicroRNA and Long Noncoding RNA as Biomarkers of Cardiovascular Diseases.
    Shi Q; Yang X
    J Cell Physiol; 2016 Apr; 231(4):751-5. PubMed ID: 26308238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating microRNA-150-5p as a novel biomarker for advanced heart failure: A genome-wide prospective study.
    Scrutinio D; Conserva F; Passantino A; Iacoviello M; Lagioia R; Gesualdo L
    J Heart Lung Transplant; 2017 Jun; 36(6):616-624. PubMed ID: 28259597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: The microRNA 221/222 Cluster: Inaugurating a New Era in Cardiovascular Disease and Cancer?
    Imprialos K; Doumas M; Tokamani M; Sandaltzopoulos R; Athyros VG
    Curr Vasc Pharmacol; 2017; 15(1):47-50. PubMed ID: 27697021
    [No Abstract]   [Full Text] [Related]  

  • 16. [MicroRNAs as Biomarkers of Cardiovascular Diseases].
    Romakina VV; Zhirov IV; Nasonova SN; Zaseeva AV; Kochetov AG; Liang OV; Tereshchenko SN
    Kardiologiia; 2018 Jan; (1):66-71. PubMed ID: 29466173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating miRNA‑21 is a promising biomarker for heart failure.
    Zhang J; Xing Q; Zhou X; Li J; Li Y; Zhang L; Zhou Q; Tang B
    Mol Med Rep; 2017 Nov; 16(5):7766-7774. PubMed ID: 28944900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do We Really Need Another Biomarker for Heart Failure?
    Stempien-Otero A
    J Card Fail; 2017 Jun; 23(6):433. PubMed ID: 28476653
    [No Abstract]   [Full Text] [Related]  

  • 19. Associations between volume status and circulating microRNAs in acute heart failure.
    Vegter EL; van der Meer P; Voors AA
    Eur J Heart Fail; 2017 Aug; 19(8):1077-1078. PubMed ID: 28547885
    [No Abstract]   [Full Text] [Related]  

  • 20. MicroRNA-214 Is Upregulated in Heart Failure Patients and Suppresses XBP1-Mediated Endothelial Cells Angiogenesis.
    Duan Q; Yang L; Gong W; Chaugai S; Wang F; Chen C; Wang P; Zou MH; Wang DW
    J Cell Physiol; 2015 Aug; 230(8):1964-73. PubMed ID: 25656649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.